Natus Medical Inc (BABY) 41.64 $BABY Natus Medical's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Natus Medical Inc (BABY) 41.64 $BABY

Natus Medical's (BABY) CEO James Hawkins on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 2:03PM CDT

BABY: 41.64 (+1.71)

Adding Up Baby Steps at Natus Medical Inc.
Brian Orelli, The Motley Fool - Motley Fool - Wed Apr 22, 1:51PM CDT
Without any large acquisitions to help artificially boost sales as we've seen in the past, Natus Medical , a purveyor of medical devices specializing in neurology and care for newborns, keeps chugging along. Revenue in the first quarter increased...
BABY: 41.64 (+1.71)

Natus Medical Incorporated (BABY) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 9:55AM CDT

BABY: 41.64 (+1.71)

Natus Medical updates guidance after Q1 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:56AM CDT

BABY: 41.64 (+1.71)

Natus Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:06AM CDT

BABY: 41.64 (+1.71)

Natus Medical Announces Record First Quarter 2015 Financial Results
GlobeNewswire - Wed Apr 22, 6:00AM CDT
-- Reports record first quarter non-GAAP earnings per share of $0.31
BABY: 41.64 (+1.71)

Natus Medical beats 1Q profit forecasts
Automated Insights - Wed Apr 22, 5:16AM CDT
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported first-quarter net income of $8.6 million.
BABY: 41.64 (+1.71)

Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:30PM CDT

DHI: 27.03 (-1.53), MKTX: 88.66 (-1.35), NLSN: 46.10 (+0.27), SEIC: 45.99 (+0.68), AZZ: 46.11 (-0.02), HBAN: 11.03 (-0.14), TDY: 109.69 (+0.48), PCH: 37.47 (-0.65), WERN: 30.29 (-1.11), NS: 65.49 (+1.78), BABY: 41.64 (+1.71), APH: 56.81 (-1.35), TEL: 70.14 (+0.13), R: 97.95 (+1.15), ANGI: 6.46 (+0.31), EVR: 50.80 (+1.28), CFG: 25.49 (+0.45), SIX: 49.97 (+1.37), EMC: 27.13 (+0.81), OC: 42.28 (-0.61), WAB: 98.61 (+2.84), BK: 42.43 (+1.39), KO: 41.31 (+0.53), LAD: 102.54 (+0.04), ABT: 48.35 (+1.23), TMO: 130.69 (-3.75), TROW: 82.59 (-0.21), SONS: 7.89 (+0.05), ALV: 120.22 (-3.47), GNTX: 18.26 (+0.09), BA: 151.19 (-2.14), TUP: 67.25 (-2.60), KNX: 32.62 (+0.07), STJ: 73.55 (+4.43), MCD: 97.84 (+2.97), AN: 65.83 (+0.93)

Natus Medical (BABY) Showing Signs Of Being Strong And Under The Radar
at The Street - Tue Apr 21, 8:57AM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 41.64 (+1.71)

Natus Receives 510(k) FDA Clearance for the Quantum High Channel Count Amplifier
GlobeNewswire - Tue Apr 21, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) announced today that it has received FDA 510(k) clearance for the Quantum amplifier; an innovative high channel count amplifier that has applications in epilepsy and seizure monitoring along with research applications.
BABY: 41.64 (+1.71)

Next Week In Biotech: Amgen, AbbVie, Biogen Earnings, UniQure CHMP, AAN Meeting
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 17, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
ABT: 48.35 (+1.23), BIIB: 423.57 (+1.46), NEO: 4.83 (-0.04), SGMO: 14.37 (-0.03), IMGN: 9.96 (+0.01), AMGN: 169.10 (+0.64), ILMN: 190.04 (-9.27), SVA: 5.06 (+0.10), BCLI: 4.29 (-0.09), ISRG: 516.93 (-29.80), BABY: 41.64 (+1.71), QURE: 26.15 (-1.44), NURO: 1.32 (-0.02), ABAX: 63.25 (-0.09), GWPH: 113.04 (-0.05), ALXN: 188.19 (+1.41), ABBV: 64.52 (+0.91), AMAG: 57.68 (+0.47), CAT: 84.87 (+0.95), MAA: 76.57 (+1.00), NVS: 103.45 (-0.62)

Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 41.64 (+1.71), DHRM: 2.92 (+0.08), IVC: 19.80 (+0.24)

My Top Health Care Equipment And Supplies Stocks For 2015
Stan Stafford - at Seeking Alpha - Fri Apr 10, 12:52PM CDT

ZMH: 117.49 (+0.12), SIRO: 93.81 (+0.60), ABMD: 69.31 (-0.40), BDX: 144.33 (-1.24), MASI: 34.96 (+0.43), IRIX: 9.81 (-0.08), ALGN: 55.94 (-0.21), CYNO: 31.52 (+0.20), GB: 54.53 (-0.02), EW: 140.87 (+0.39), ANIK: 38.68 (+0.05), ERB: 3.04 (-0.30), BABY: 41.64 (+1.71), GMED: 25.09 (-0.16), BAX: 70.38 (+0.33), STJ: 73.55 (+4.43), INGN: 36.39 (-0.04)

BUYINS.NET: GD, BABY, HERO, CP, DD Expected To Be Up Before Next Earnings Releases
M2 - Fri Apr 10, 6:59AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and April earnings reports. General Dynamics Corp (NYSE:GD), NATUS MEDICAL, INCORPORATION (NASDAQ:BABY), Hercules Offshore Inc (NASDAQ:HERO), Canadian Pacific Railway Ltd (NYSE:CP), E. I. du Pont de Nemours and Co (NYSE D) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Wednesday:
HERO: 0.66 (-0.05), BABY: 41.64 (+1.71), GD: 133.71 (+0.57), DD: 71.44 (+0.75), CP: 195.00 (+6.08)

Germany Blood Pressure Monitors Market Growth Trends 2007-2020 - Mercury BP Monitors, Aneroid BP Monitors & Automatic BP Monitors
M2 - Wed Apr 08, 8:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/22d49c/germany_blood) has announced the addition of the "Germany Blood Pressure Monitors Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the blood pressure monitors in Germany through 2020. The product categories covered in this report include: - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors Scope - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Charts 2. Introduction 3. Scope of the Report 4. German Market for Blood Pressure Monitors, 2007-2020 4.1 Blood Pressure Monitors, Revenue ($ mn) by Sub-Category, 2007-2020 4.2 Blood Pressure Monitors, Volume (Units) by Sub-Category, 2007-2020 4.3 Blood Pressure Monitors, Average Price ($), 2007-2020 4.4 Blood Pressure Monitors, Company Shares (%), 2014 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Medical Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/22...many_blood
ABT: 48.35 (+1.23), MDT: 78.01 (+0.93), CAH: 91.50 (+1.15), COV: 106.71 (-1.36), EW: 140.87 (+0.39), MR: 31.77 (+0.62), BSX: 18.41 (+0.10), CMD: 92.72 (unch), BABY: 41.64 (+1.71), ALOT: 14.01 (+0.10), STJ: 73.55 (+4.43)

France Sleep Apnea Diagnostic Systems Market Growth Trends 2007-2020
M2 - Wed Apr 08, 8:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcwwpc/france_sleep) has announced the addition of the "France Sleep Apnea Diagnostic Systems Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in France through 2020. The product categories covered in this report include: - Fixed Polysomnography Systems - Portable Polysomnography Systems Scope - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Charts 2. Introduction 3. Scope of the Report 4. French Market for Sleep Apnea Diagnostic Systems, 2007-2020 4.1 Sleep Apnea Diagnostic Systems, Revenue ($ mn) by Sub-Category, 2007-2020 4.2 Sleep Apnea Diagnostic Systems, Volume (Units) by Sub-Category, 2007-2020 4.3 Sleep Apnea Diagnostic Systems, Average Price ($), 2007-2020 4.4 Sleep Apnea Diagnostic Systems, Company Shares (%), 2014 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/bc...ance_sleep
ABT: 48.35 (+1.23), CAH: 91.50 (+1.15), COV: 106.71 (-1.36), EW: 140.87 (+0.39), BSX: 18.41 (+0.10), CMD: 92.72 (unch), BABY: 41.64 (+1.71), ALOT: 14.01 (+0.10), RMD: 73.28 (+0.17)

Natus Medical to Hold 2015 First Quarter Financial Results Conference Call on April 22nd
GlobeNewswire - Wed Apr 08, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company will release its 2015 first quarter financial results before the market opens on Wednesday, April 22. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
BABY: 41.64 (+1.71)

The Best Small Cap Stocks To Buy Now
Todd Campbell - at Seeking Alpha - Mon Apr 06, 4:40AM CDT

PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), SNHY: 40.71 (+0.16), EBIX: 29.77 (+0.86), SWHC: 14.68 (-0.12)

Today's Strong And Under The Radar Stock: Natus Medical (BABY)
at The Street - Thu Apr 02, 12:57PM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 41.64 (+1.71)

The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Mar 30, 9:19AM CDT

OCR: 84.52 (+3.45), ELLI: 57.00 (-0.45), JCOM: 70.72 (-0.38), CAH: 91.50 (+1.15), AET: 107.95 (-0.41), BABY: 41.64 (+1.71), DFT: 32.24 (-0.18), NLNK: 53.12 (-0.07), HSIC: 141.11 (+1.14), MNK: 122.95 (-2.22), CAVM: 73.16 (+0.39), HAS: 71.73 (-1.82), BCR: 175.09 (+0.24), MCHP: 49.30 (+0.08), MYL: 72.40 (-1.67), NXPI: 102.69 (+1.45), EV: 43.60 (+0.19), NVDA: 22.31 (+0.25), LVLT: 54.24 (-0.04), CBRL: 137.40 (-1.10), MTSI: 34.46 (-0.27), AZO: 693.41 (+2.68), EQIX: 244.78 (+1.00), IRWD: 15.07 (-0.19), AVB: 170.64 (+1.59), KNX: 32.62 (+0.07), HAE: 42.33 (-0.21), FSL: 41.53 (+0.49), FHN: 14.49 (+0.06), BDX: 144.33 (-1.24), ACT: 295.22 (+0.69), F: 15.91 (+0.09), AON: 97.20 (+0.10), NUVA: 43.38 (+0.10), CDW: 38.93 (+0.21), ANTM: 152.84 (-0.04), APH: 56.81 (-1.35), INFA: 47.92 (-0.03), EXAM: 42.52 (-0.16), LII: 107.70 (+2.09), BJRI: 50.54 (-1.00), BDN: 14.90 (+0.14), DPZ: 99.80 (+0.40), FL: 60.00 (-0.08), DLX: 69.57 (+0.47), ABT: 48.35 (+1.23), BMR: 21.37 (+0.14), HCN: 75.44 (+0.21), DIOD: 28.02 (+0.12), LEG: 44.32 (unch), DIS: 107.94 (+0.26), GLW: 22.44 (-0.17), MAR: 80.78 (+0.31), ASML: 107.81 (+10.06), IMAX: 37.51 (+0.51), CNC: 70.90 (+0.12), CTAS: 82.05 (+0.01), FLO: 22.50 (-0.03), CRM: 67.71 (+0.33)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 235

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 269

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 210

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 355

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 227

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 158

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Banyan Wins Inc. Power Partner Award for 3rd Year

Updated Category News Views 50

Red Banyan: A Powerhouse in B2B Support Red Banyan isn't just any player in the communications game; it's carved out a reputation as the go-to when businesses hit rough waters. You see, for the third consecutive year, this Fort Lauderdale-based firm bagged the Inc. Power Partner Award—a nod to its clout in the B2B arena. This accolade ain't about fancy ads; it's about...

Continue Reading
REA Group Pursues Rightmove Acquisition to Expand Globally

Updated Category News Views 85

REA Group's Bold Step into the UK Real Estate Market REA Group Ltd, a subsidiary of News Corporation, is stirring things up in the real estate sector with its recent proposal to acquire Rightmove plc, one of the UK's top real estate portals. This non-binding offer shows REA Group's ambitions to grow beyond Australia and tap into new international markets. Plans for...

Continue Reading
SiriusXM Announces Quarterly Dividend for Investors

Updated Category News Views 156

SiriusXM Announces Quarterly Cash Dividend SiriusXM (NASDAQ: SIRI) recently shared an important update with its shareholders. The Board of Directors has declared a quarterly cash dividend amounting to $0.27 per share of common stock. This significant step reflects the company’s ongoing commitment to providing value to its investors. Dividend Payment Details Stockholders...

Continue Reading
Market Update: IDX Composite Index Experiences Minor Decline

Updated Category News Views 200

Indonesia Stock Market: Daily Overview Trading on the Indonesian stock exchange finished a touch lower, with the IDX Composite Index slipping 0.06%. Losses in Infrastructure, Agriculture, and Basic Industry set the tone, and modest gains elsewhere weren’t enough to change the direction. It was a cautious, choppy session that underlined a still-challenging backdrop. Key...

Continue Reading
Innovative Snow and Ice Clearing Tool Revolutionizes Vehicle Care

Updated Category News Views 171

Revolutionary Ice Clearing Tool for Vehicles In the winter months, battling ice and snow on car windows can be a frustrating experience for many drivers. Recognizing this challenge, an inventive mind has come up with a solution that promises to change the way we deal with this common problem. The new design, known as the ICE SCRAPER, has been developed to enhance the...

Continue Reading